These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4981598)

  • 1. Responses to Rh challenge.
    Gusdon JP
    Obstet Gynecol; 1969 Nov; 34(5):744-6. PubMed ID: 4981598
    [No Abstract]   [Full Text] [Related]  

  • 2. Responses to Rh challenge.
    Queenan JT
    Obstet Gynecol; 1969 Nov; 34(5):747-9. PubMed ID: 4186856
    [No Abstract]   [Full Text] [Related]  

  • 3. Responses to Rh challenge.
    Visscher RD; Visscher HC
    Obstet Gynecol; 1969 Nov; 34(5):746-7. PubMed ID: 4186855
    [No Abstract]   [Full Text] [Related]  

  • 4. The future of Rh immune globulin.
    Gorman JG
    Ann Ostet Ginecol Med Perinat; 1970 Jul; 92(7):422-6. PubMed ID: 5003518
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention of Rh sensitization from fetomaternal microtransfusions.
    Schneider J; Preisler O
    Obstet Gynecol; 1966 Nov; 28(5):615-21. PubMed ID: 4958982
    [No Abstract]   [Full Text] [Related]  

  • 6. [Further comments on an unusual transfusion complication].
    Orv Hetil; 1983 Dec; 124(49):3024. PubMed ID: 6419193
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical experience with a new preparation of Rh 0 (D) immune globulin (human).
    Wurzel JF; Hansen LM; Evensen KL
    Obstet Gynecol; 1973 May; 41(5):760-4. PubMed ID: 4633212
    [No Abstract]   [Full Text] [Related]  

  • 8. No excuse for Rh failure.
    Robertson WO
    Northwest Med; 1969 Oct; 68(10):925 passim. PubMed ID: 4981721
    [No Abstract]   [Full Text] [Related]  

  • 9. [Letter: Fetomaternal blood incompatibilities in Rh positive women].
    Senecal J; Le Marec B; Genetet B; Bonnefoy O; Le Freche J
    Nouv Presse Med; 1976 May; 5(18):1211. PubMed ID: 818622
    [No Abstract]   [Full Text] [Related]  

  • 10. [The prophylaxis of rhesus sensitization with immunoglobulin-anti-D].
    Schneider J; Preisler O
    Arztl Forsch; 1967 Nov; 21(11):414-20. PubMed ID: 4970408
    [No Abstract]   [Full Text] [Related]  

  • 11. [Transfusion complications caused by rarely occurring non-D antibodies].
    Orv Hetil; 1983 Feb; 124(9):545. PubMed ID: 6405339
    [No Abstract]   [Full Text] [Related]  

  • 12. [Ensuring prevention of Rh immunization by the transfusion service].
    Novák J
    Vnitr Lek; 1974 Sep; 20(9):889-91. PubMed ID: 4212645
    [No Abstract]   [Full Text] [Related]  

  • 13. [Electrophoretic study of serum proteins in female donors immunized against Rh factor].
    Poperechnaia SI; Dobroserdova TB
    Probl Gematol Pereliv Krovi; 1974 Apr; 19(4):34-7. PubMed ID: 4134107
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prevention of D-sensitization after administration of Rh-positive blood in a Rh-negative receptor].
    Dieckmann W; Schneider W; Schunter F; Zapata M
    Med Welt; 1971 Jan; 3():116-8. PubMed ID: 4993562
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention of primary Rh immunization: first report of the Western Canadian trial, 1966-1968.
    Can Med Assoc J; 1969 Jun; 100(22):1021-4. PubMed ID: 4977545
    [No Abstract]   [Full Text] [Related]  

  • 16. Thoughts and questions on the role of the D u factor in Rh prophylaxis.
    Eldon K
    Ann Ostet Ginecol Med Perinat; 1970 Jul; 92(7):454. PubMed ID: 5003527
    [No Abstract]   [Full Text] [Related]  

  • 17. [Avoidance of incidents in erythroblastosis prevention with immune gamma globulin (IgG) anti-D. Remarks to R. Lipp, Munchen Med Wschr 110 (1968) 37, 2091-4].
    Deicher H; Hoppe HH; Schellong G; Schneider J; Welsch H
    Munch Med Wochenschr; 1969 Feb; 111(8):437-42. PubMed ID: 4977170
    [No Abstract]   [Full Text] [Related]  

  • 18. Prophylaxis of maternal RH-sensitization by means of anti-D immunoglobulin.
    Petrov-Maslakov MA; Vasilyeva ZF; Matveyeva OF; Balasanyan IG; Sorina LI; Prigarnova TK
    Arch Immunol Ther Exp (Warsz); 1971; 19(3):343-8. PubMed ID: 4999474
    [No Abstract]   [Full Text] [Related]  

  • 19. The production of anti-D preparations used in the prevention of Rh immunization.
    Hughes-Jones NC; Holburn AM; Cleghorn TE
    Vox Sang; 1969 Apr; 16(4):418-20. PubMed ID: 4979250
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prevention of Rhesus-sensitization by intravenous administration of immunoglobulin G anti-D. II. General prevention using low doses of IgG anti-D, adapted to the extent of fetomaternal transfusion].
    Börner P; Deicher H; Ghani G; Geldmacher H; Kayser D; Kahnt P; Klang D; Klaus H; Marks V; Nehawandian OA
    Geburtshilfe Frauenheilkd; 1971 Oct; 31(10):911-23. PubMed ID: 5002413
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.